WAVE Life Sciences (WVE) Misses Q2 EPS by 11c

WAVE Life Sciences (NASDAQ: WVE) reported Q2 EPS of ($0.62), $0.11 worse than the analyst estimate of ($0.51).

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• KeyBanc Reiterates Overweight Rating on Brinker Int'l (EAT)
• LEEF Brands appoints Hirsh Jain to board as independent director